Status:

COMPLETED

Efficacy and Safety Study of Avastin to Treat Neovascularisation of the Cornea

Lead Sponsor:

University Hospital, Limoges

Conditions:

Corneal Newvessels

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Corneal newvessels may arise from a fan of pathologies, inducing long-standing corneal opacification requiring keratoplasty. These last years, VEGF inhibitors have been designed to reduce newasculariz...

Detailed Description

This study will involve 42 outpatients of the CHU of Limoges, Bordeaux, and Toulouse, addressed for corneal pathologies including corneal newvessels. The patients will be randomly assigned to two grou...

Eligibility Criteria

Inclusion

  • inclusion criteria:
  • Patients with corneal neovascularization whatever the origin
  • Patient did not receive treatment with topical corticosteroids during the month preceding inclusion.
  • Patient who has been properly informed and signed consent
  • Patient aged over 18
  • Patient affiliated with a health insurance plan or benefit of such a regime

Exclusion

  • Patients who received local or general treatment of concomitant prostaglandin derivatives
  • Patients with current infection of the cornea or other tissue / organ
  • Women of childbearing age without contraception
  • Pregnancy and Lactation
  • Patient participating in another study
  • Patient with contact lenses
  • Patients with uncontrolled hypertension
  • Patient with a history of stroke, myocardial infarction, angina pectoris, thrombophlebitis, Raynaud's phenomenon.
  • Patients hypersensitive to the active substance or any excipients
  • Patients hypersensitive to products of Chinese hamster ovary cells or other recombinant human or humanized antibodies.
  • Patients with active bacterial eye infections, fungal, parasitic or viral infection (with the exception of herpes)

Key Trial Info

Start Date :

May 13 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2019

Estimated Enrollment :

38 Patients enrolled

Trial Details

Trial ID

NCT01501760

Start Date

May 13 2012

End Date

October 1 2019

Last Update

October 24 2019

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Service d'Ophtalmologie

Limoges, France, 87042

2

CHU Poitiers-Ophtalmologie

Poitiers, France, 86021

3

CHU St Etienne

Saint-Etienne, France

4

CHU Strasbourg- Service Ophtalmlogie

Strasbourg, France, 67000

Efficacy and Safety Study of Avastin to Treat Neovascularisation of the Cornea | DecenTrialz